Transgene to Participate in Upcoming Investor Meetings

Remarks by FDA Chief Scientist Denise Hinton to the Professional Services Council FedHealth Conference - 03/11/2021

Remarks by FDA Chief Scientist Denise Hinton to the Professional Services Council FedHealth Conferen...

Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology PipelineTubuli

Welcoming our new Chief Executive, Mat Shaw

CORMEDIX TO PARTICPATE IN NEEDHAM VIRTUAL HEALTHCARE CONFERENCE

Variational AI releases Enki 4: Major update to foundation model for small- molecule drug discovery

Ergomed Group Announces Board Chair Transition

PathAI and MedStar Health Announce Partnership to Deploy the AISight® Dx Digital Pathology Platform and Advanced AI Applications

Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors

Building Effective Long-Term Follow-Up Strategies in Advanced Therapies

Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month

Natac’s CEO presents SustaiNext as an example of industrial scale-up at the CBE JU Stakeholder Forum 202607/04/2026Industrial biotechnologyAntonio Delgado participated in the panel “From lab to fab: enabling scale up of bio-based…Partners - Natac Group

Antonio Delgado participated in the panel “From lab to fab: enabling scale up of bio-based innovatio...

NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia

YPrime Expands eCOA Platform with Participant Hub

TriNetX Enhances its Ability to Federate Genomics Data Across its Global Network of Providers through the Acquisition of Key Assets of Zetta Genomics

Scientists identify ‘neural fingerprint’ of psychedelic drugs in the brain

Good luck #teamUCLH in the London Landmarks Half Marathon

COVID-19 spring booster available for eligible groups

Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit

SAN DIEGO, April 07, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinic...

Alloy Therapeutics Enters into Multi-Target Collaboration and License Agreement with Biogen for Use of Alloy’s AntiClastic™ ASO Platform

How stem cell descendants preserve flexibility while maintaining distinct identities

USP Revisions: What They Mean for Injectable Drug Quality and Why Packaging Matters More Than Ever

USP updates on particulate matter standards clarify subvisible particle testing requirements and the...

Read the Press Release

Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma...

TuHURA Biosciences, Inc.

tuhura biosciences appoints amanda garofalo mshs as senior vice president of clinical operations 302735470

Pharming Group to participate in April investor conferencesConference attendanceApril 7 2026Pharming Group N.V. today announced that its management will participate in the following investor conferences in the month of April:Read more

Pharmacists at Orion – The many paths a pharmacy degree can open up in the pharmaceutical industry4/7/2026 We are Orion Pharma

Pharmacy-trained professionals are in high demand across the pharmaceutical industry – from supply c...

News Published on 2026/04/07 タグ University News FY2026 Undergraduate Entrance Ceremony held

ISPOR Publishes Recommendations on Valuing Child and Adolescent Health for Economic Evaluations

Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline

The Analytical Scientist: Vibe Coding Comes to Omics

Jesse Meyer, PhD, told The Analytical Scientist how he used AI-powered vibe coding to build in minut...

Member Press Releases Apr 07, 2026Variational AI – Releases Enki 4: Major Update to Foundation Model for Small-Molecule Drug DiscoveryRead More

Variational AI introduces Enki™ 4: an improved algorithm and architecture designed to scale, expandi...

Spot the phish in less than five minutes

You can learn to spot phishing attempts in less than five minutes. Check out these two videos from L...

Cell & Gene Covers the “Challenges with Implementing Annex 1 at the Global Level” Session from the 2026 ISPE Aseptic Conference

During the 2026 ISPE Aseptic Conference, Franck Bure, Principal Quality Technical Manager, Genentech...

Nuvalent Announces Submission of New Drug Application to FDA for Neladalkib in TKI Pre-treated Advanced ALK-positive NSCLC

New Drug Application (NDA) based on data in TKI pre-treated patients from the global ALKOVE-1 Phase...

acadia pharmaceuticals announces daybue stix trofinetide is now broadly available in the united states for the treatment of rett syndrome

DAYBUE STIX is a new powder formulation of trofinetide - Recently published expert consensus recogni...

‘A cure on the horizon’: Are we finally close to ending type 1 diabetes?

Health-oriented Management Declaration

Reprotech and TMRW Life Sciences enter into Business Combination to Create the Most Comprehensive Technology-Enabled Cryostorage Company in Fertility

The New AccelStim: Advanced Features, Same Proven Results

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cancer, climate change, fossil fuels, and war: a call for action

Sound mind, sound place: ibasho and post-disaster mental health

Q&A: Ezekiel Emanuel's simple rules

BP-lowering drugs reduced major CV events to a similar extent in patients with or without isolated diastolic hypertension

Multisite External Validation of a Clinical Screening Tool for Interpersonal Firearm Violence Risk

In MINOCA, stratified treatment guided by MINOCA cause vs. standard care improved angina status at 1 y

In sepsis, a tailored precision immunotherapy strategy improved organ function at 9 d

In patients with painful diabetic neuropathy, pregabalin does not differ from duloxetine for pain

In the ED, the Wells score plus age-adjusted D-dimer score ruled out DVT with a failure rate ≤0.8% at 3 mo

In patients with chronic lung disease, 4 existing PE diagnostic strategies were assessed

In adults with ADHD, atomoxetine, methylphenidate, and CBT reduce symptom severity and the drugs are less tolerable vs. control at 12 wk

Summary for Patients: Multisite External Validation of a Clinical Screening Tool for Interpersonal Firearm Violence Risk

After ischemic stroke in patients receiving aspirin, switching to another antithrombotic regimen does not reduce recurrence

First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in Leukemia

Frazier Life Sciences Appoints Christian Schade as Senior Advisor

ask our experts monoclonal antibodies explained

Watch our experts answer some common questions we’ve received from veterinarians about monoclonal an...

Products / Services

About Tokyo Electron's Products and Service News

2026.04.06æ ªä¸»ç ä¼šã®Q&Aã‚’å ¬é–‹ã—ã¾ã—ãŸ